Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:monoclonal_antibody
investigational drug |
| gptkbp:alternativeName |
gptkb:HL161
gptkb:IMVT-1401 |
| gptkbp:CASNumber |
2228321-98-8
|
| gptkbp:clinicalTrialPhase |
Phase 3 (as of 2024)
|
| gptkbp:developedBy |
gptkb:Immunovant
autoimmune diseases |
| https://www.w3.org/2000/01/rdf-schema#label |
batoclimab
|
| gptkbp:indication |
gptkb:chronic_inflammatory_demyelinating_polyneuropathy
gptkb:myasthenia_gravis thyroid eye disease |
| gptkbp:mechanismOfAction |
FcRn antagonist
|
| gptkbp:routeOfAdministration |
subcutaneous
|
| gptkbp:target |
neonatal Fc receptor (FcRn)
|
| gptkbp:bfsParent |
gptkb:Roivant_Sciences
|
| gptkbp:bfsLayer |
5
|